Latest News and Press Releases

Expanded from 9 to 10 warehouses throughout the first half of fiscal year 2025Total warehouse space increased from 2 million to over 3.5 million square feetMajor presence in California, Georgia...

Strong EU51 revenue growth: +12% year-on-yearTotal revenues at €480m, up 11%2 year-on-yearTotal EBITDA of €165m, up 14% year-on-year and EBITDA margin of 34.4%Strong cash flow generation and continued...

Reported Full Year 2023 total revenues of 2% growth at €48.5 millionSecured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company owned...

First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue...

Full Year 2022 total revenues with double-digit growth of 12% at €47.5 million, in line with prior guidanceSignificant expansion of gross profit margin from 32% to 42% and ongoing cost control...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...

Une croissance forte et rentable Les revenus totaux ont augmenté de 125 % par rapport à l’année précédente pour atteindre 7,1 millions de dollars grâce à la vente de billets des films à grands succès...

Highlighted by strong profitable growth Total revenues increased 125% year-over-year to $7.1 million, driven by ticket sales of blockbuster movies and full reopening of entertainment venuesRights for...

On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business segment in Q1 2022Positioning Pharma and Diagnostics for post-COVID recovery and...

Croissance des revenus de 92 % et BAIIA ajusté positif T4 2022 Les revenus totaux ont augmenté de 137 % par rapport au même trimestre de l’exercice précédent pour atteindre 7,0 millions de...